Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYME for Anterior Capsule Staining in Cataract Surgery
NCT00596492Phase 3Terminated
- Sponsor
- Aqumen Biopharmaceuticals
- Start
- May 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of brilliant blue G in cataract, sponsored by Aqumen Biopharmaceuticals. Started May 2008; status: terminated.
02
Drugs
brilliant blue G
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00596492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596492.